Literature DB >> 10506086

Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.

G R Mallucci1, T A Campbell, A Dickinson, J Beck, M Holt, G Plant, K W de Pauw, R N Hakin, C E Clarke, S Howell, G A Davies-Jones, M Lawden, C M Smith, P Ince, J W Ironside, L R Bridges, A Dean, I Weeks, J Collinge.   

Abstract

A large English family with autosomal dominant segregation of presenile dementia, ataxia and other neuropsychiatric features is described. Diagnoses of demyelinating disease, Alzheimer's disease, Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker syndrome have been attributed to particular individuals at different times. An Irish family, likely to be part of the same kindred, is also described, in which diagnoses of multiple sclerosis, dementia, corticobasal degeneration and new variant CJD have been considered in affected individuals. Molecular genetic studies have enabled the classification of this disease at the molecular level as one of the group of inherited prion diseases, with the substitution of valine for alanine at codon 117 of the prion protein gene (PRNP). Only three other kindreds have been described world-wide with this mutation and only limited phenotypic information has been reported. Here we describe the phenotypic spectrum of inherited prion disease (PrPA117V). The diversity of phenotypic expression seen in this kindred emphasizes the logic of molecular classification of the inherited prion diseases rather than classification by specific clinicopathological syndrome. Indeed, inherited prion disease should be excluded by PRNP analysis in any individual presenting with atypical presenile dementia or neuropsychiatric features and ataxia, including suspected cases of new variant CJD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506086     DOI: 10.1093/brain/122.10.1823

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

Review 1.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

2.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

3.  Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.

Authors:  Christopher F Harrison; Victoria A Lawson; Bradley M Coleman; Yong-Sun Kim; Colin L Masters; Roberto Cappai; Kevin J Barnham; Andrew F Hill
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

4.  A case of Gerstmann-Sträussler-Scheinker disease with a novel six octapeptide repeat insertion.

Authors:  A Vital; J-L Laplanche; J-R Bastard; X Xiao; W-Q Zou; C Vital
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

5.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

6.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

7.  Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan.

Authors:  Nai-Fang Chi; Yi-Chung Lee; Yi-Chun Lu; Hsiu-Mei Wu; Bing-Wen Soong
Journal:  J Neurol       Date:  2009-08-21       Impact factor: 4.849

Review 8.  Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.

Authors:  Mark P Figgie; Brian S Appleby
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

9.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

10.  Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Michelle Smidak; Andrew Tomlinson; Andrew Grimshaw; Asif Jeelani; Tatiana Jakubcova; Shyma Hamdan; Caroline Powell; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.